Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393 · see citing works

Random-Effects Models for Longitudinal Data

Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923 · see citing works

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., & Markowitz, M. H. (1995) · Nature · doi:10.1038/373123a0 · Cited by 4,261 · see citing works

HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

Perelson, A. S., Neumann, A. U., Markowitz, M. H., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,533 · see citing works

Viral dynamics in human immunodeficiency virus type 1 infection

Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., et al. (1995) · Nature · doi:10.1038/373117a0 · Cited by 3,259 · see citing works

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098 · see citing works

Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,658 · see citing works

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Hammer, S. M., Squires, K., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J., Balfour, H. H., Deyton, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,638 · see citing works

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

Nabel, G. J., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,076 · see citing works

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · see citing works

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Chun, T., Stuyver, L. J., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,960 · see citing works

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Gulick, R. M., Mellors, J. W., Havlir, D. V., Eron, J. J., Gonzalez, C. J., McMahon, D. K., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,883 · see citing works

Decay characteristics of HIV-1-infected compartments during combination therapy

Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M. H., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,861 · see citing works

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,832 · see citing works

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808 · see citing works

HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure

Zack, J. A., Arrigo, S. J., Weitsman, S. R., Go, A. S., Haislip, A., & Chen, I. S. Y. (1990) · Cell · doi:10.1016/0092-8674(90)90802-l · Cited by 1,517 · see citing works

High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR

Piatak, M., Saag, M. S., Yang, L., Clark, S. J., Kappes, J. C., Luk, K., Hahn, B. H., Shaw, G. M., & Lifson, J. D. (1993) · Science · doi:10.1126/science.8096089 · Cited by 1,230 · see citing works

Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons

Ho, D. D., Moudgil, T. L., & Alam, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912143212401 · Cited by 1,061 · see citing works

Antiretroviral Therapy for HIV Infection in 1998

Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., et al. (1998) · JAMA · doi:10.1001/jama.280.1.78 · Cited by 995 · see citing works

HIV-Protease Inhibitors

Flexner, C. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381808 · Cited by 842 · see citing works

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

Daar, E. S., Moudgil, T. L., Meyer, R. D., & Ho, D. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104043241405 · Cited by 834 · see citing works

In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

Chun, T., Finzi, D., Margolick, J. B., Chadwick, K. R., Schwartz, D. H., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787 · see citing works

Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization.

Harper, M., Marselle, L. M., Gallo, R. C., & Wong‐Staal, F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.772 · Cited by 716 · see citing works

The Reservoir for HIV-1 in Human Peripheral Blood Is a T Cell That Maintains Expression of CD4

Schnittman, S., Psallidopoulos, M. C., Lane, H. C., Thompson, L., Baseler, M., Massari, F. E., Fox, C. H., Salzman, N. P., & Fauci, A. S. (1989) · Science · doi:10.1126/science.2665081 · Cited by 714 · see citing works

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Folks, T. M., Clouse, K. A., Justement, J. S., Rabson, A. B., Duh, E. J., Kehrl, J. H., & Fauci, A. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2365 · Cited by 701 · see citing works

HIV-1 protease inhibitors. A review for clinicians

Deeks, S. G. (1997) · JAMA · doi:10.1001/jama.277.2.145 · Cited by 686 · see citing works

Quiescent T Lymphocytes as an Inducible Virus Reservoir in HIV-1 Infection

Bukrinsky, M., Stanwick, T. L., Dempsey, M. P., & Stevenson, M. (1991) · Science · doi:10.1126/science.1925601 · Cited by 590 · see citing works

Plasma Viremia in Human Immunodeficiency Virus Infection

Coombs, R. W., Collier, A. C., Allain, J.-P., Nikora, B., Leuther, M. D., Gjerset, G. F., & Corey, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912143212402 · Cited by 558 · see citing works

Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Pantaleo, G., Graziosi, C., Butini, L., Pizzo, P. A., Schnittman, S., Kotler, D. P., & Fauci, A. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9838 · Cited by 499 · see citing works

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

Chun, T., Engel, D., Mizell, S. B., Hallahan, C. W., Fischette, M. R., Park, S., Davey, R. T., Dybul, M. R., Kovacs, J. A., Metcalf, J. A., et al. (1999) · Nature Medicine · doi:10.1038/9498 · Cited by 403 · see citing works

Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency

Pomerantz, R. J., Trono, D., Feinberg, M. B., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90691-7 · Cited by 365 · see citing works

Medical Management of HIV Infection

Bartlett, J. G., Gallant, J. E., & Pham, P. A. (1996) · Medical Entomology and Zoology · Cited by 329 · see citing works

In vivo estimates of division and death rates of human T lymphocytes.

Mclean, A. R., & Michie, C. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3707 · Cited by 270 · see citing works

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure

Wong, J. K., Günthard, H. F., Havlir, D. V., Zhang, Z.-Q., Haase, A. T., Ignacio, C. C., Kwok, S., Emini, E. A., & Richman, D. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12574 · Cited by 238 · see citing works

Human Immunodeficiency Virus Replication and Genotypic Resistance in Blood and Lymph Nodes after a Year of Potent Antiretroviral Therapy

Günthard, H. F., Wong, J. K., Ignacio, C. C., Guatelli, J., Riggs, N. L., Havlir, D. V., & Richman, D. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2422-2428.1998 · Cited by 204 · see citing works

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

Jacobson, E. L., Pilaro, F., & Smith, K. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10405 · Cited by 166 · see citing works

Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.

Folks, T., Kelly, J. B., Benn, S., et al. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.11.4049 · Cited by 164 · see citing works

Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals

Psallidopoulos, M. C., Schnittman, S., Thompson, L., Baseler, M., Fauci, A. S., Lane, H. C., & Salzman, N. P. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4626-4631.1989 · Cited by 153 · see citing works

Molecular Basis of Latency in Pathogenic Human Viruses

García-Blanco, M. A., & Cullen, B. R. (1991) · Science · doi:10.1126/science.1658933 · Cited by 150 · see citing works

HIV-1 replication in patients with undetectable plasma virus receiving HAART

Natarajan, V., Bosche, M. C., Metcalf, J. A., Ward, D. J., Lane, H. C., & Kovacs, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76156-0 · Cited by 140 · see citing works

Dilution assay statistics

Myers, L. E., McQuay, L. J., & Hollinger, F. B. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.3.732-739.1994 · Cited by 134 · see citing works

Correlation of Virus Load in Plasma and Lymph Node Tissue in Human Immunodeficiency Virus Infection

Harris, M., Patenaude, P., Cooperberg, P. L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/517328 · Cited by 28 · see citing works

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Siliciano, J. D., Kajdas, J., Finzi, D., Quinn, T. C., Chadwick, K., Margolick, J. B., Kovacs, C., Gange, S. J., & Siliciano, R. F. (2003) · Nature Medicine · doi:10.1038/nm880 · Cited by 1,703 · see citing works

Timing the ancestor of the HIV-1 pandemic strains.

Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021 · see citing works

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro

Jordan, A., Bisgrove, D., & Verdin, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg188 · Cited by 914 · see citing works

Defective proviruses rapidly accumulate during acute HIV-1 infection

Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737 · see citing works

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., & Schneider, T. (2011) · Blood · doi:10.1182/blood-2010-09-309591 · Cited by 681 · see citing works

Redefining the Viral Reservoirs that Prevent HIV-1 Eradication

Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474 · see citing works

Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.

Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508952 · Cited by 283 · see citing works

Accelerated immune senescence and HIV-1 infection

APPAY, V, ALMEIDA, J., SAUCE, D., AUTRAN, B., & PAPAGNO, L. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.12.003 · Cited by 236 · see citing works

Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase

Murray, J. M., Emery, S., Kelleher, A. D., Law, M., Chen, J., Hazuda, D. J., Nguyen, B.-Y. T., Teppler, H., & Cooper, D. A. (2007) · AIDS · doi:10.1097/qad.0b013e3282f12377 · Cited by 187 · see citing works

HIV reservoirs: pathogenesis and obstacles to viral eradication and cure

Chun, T.-W., & Fauci, A. S. (2012) · AIDS · doi:10.1097/qad.0b013e328353f3f1 · Cited by 175 · see citing works

Premature ageing of the immune system: the cause of AIDS?

Appay, V., & Rowland-Jones, S. L. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02338-4 · Cited by 173 · see citing works

Newer Gene Editing Technologies toward HIV Gene Therapy

Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013) · Viruses · doi:10.3390/v5112748 · Cited by 77 · see citing works

Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection

Barton, K. M., Archin, N. M., Keedy, K. S., Espeseth, A. S., Zhang, Y.-L., Gale, J., Wagner, F. F., Holson, E. B., & Margolis, D. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102684 · Cited by 76 · see citing works

Pre-clinical Modeling of CCR5 Knockout in Human Hematopoietic Stem Cells by Zinc Finger Nucleases Using Humanized Mice

Hofer, U., Henley, J. E., Exline, C. M., Mulhern, O., Lopez, E., & Cannon, P. M. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit382 · Cited by 43 · see citing works

HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells

Pace, M. J., Graf, E. H., & O'Doherty, U. (2013) · Virology · doi:10.1016/j.virol.2013.02.028 · Cited by 34 · see citing works

Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4 ⁺ T Cell Subsets during Long-Term Combination Antiretroviral Therapy

Jones, B. R., Miller, R. L., Kinloch, N. N., Tsai, O., Rigsby, H., Sudderuddin, H., Shahid, A., Ganase, B., Brumme, C. J., Harris, M., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01786-19 · Cited by 29 · see citing works

Current State of Therapeutics for HTLV-1

Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22 · see citing works

Herpes simplex virus type 1 latency-associated transcription plays no role in establishment or maintenance of a latent infection in murine sensory neurons

Sedarati, F., Izumi, K. M., Wagner, E. K., et al. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4455-4458.1989 · Cited by 107 · see citing works

From reactivation of latent HIV‐1 to elimination of the latent reservoir: The presence of multiple barriers to viral eradication

Shan, L., & Siliciano, R. F. (2013) · BioEssays · doi:10.1002/bies.201200170 · Cited by 83 · see citing works

Inducible Cyclic AMP Early Repressor Produces Reactivation of Latent Herpes Simplex Virus Type 1 in Neurons In Vitro

Colgin, M. A., Smith, R. L., & Wilcox, C. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2912-2920.2001 · Cited by 41 · see citing works

Analyses of herpes simplex virus type 1 latency and reactivation at the single cell level using fluorescent reporter mice

Proença, J. T., Nelson, D. E., Nicoll, M. P., et al. (2015) · Journal of General Virology · doi:10.1099/jgv.0.000380 · Cited by 17 · see citing works

The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections

Thompson, R., & Sawtell, N. M. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0071-0 · Cited by 45 · see citing works